RT @DAielloMD
3/26 #TumorBoardTuesday #LCSMMini tweetorial 1
️~10.5% of pts w SCC have actionable alterations
Consider NGS in nonadeno #NSCLC pts who
or light
hx (1-10 pack yrs)
young age (dx age <50)
bc potentially prevalence driver muts
@IASLC https://www.jto.org/article/S1556-0864(17)33071-X/fulltext#secsectitle0095